Regulatory T cells and type 1 diabetes
- PMID: 15794912
- DOI: 10.1007/s11892-005-0036-x
Regulatory T cells and type 1 diabetes
Abstract
Regulatory T cells are now recognized as important mediators of self-tolerance and may mediate responses to immune therapy. The mechanisms of action of these cells are diverse, and some studies suggest that there may be defects in regulatory cells in patients with type 1 diabetes. These cells may be expanded by immune therapy, suggesting the possible development of adoptive immune therapy to transfer regulation with the cells.
Similar articles
-
CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.J Autoimmun. 2003 Nov;21(3):221-37. doi: 10.1016/s0896-8411(03)00114-8. J Autoimmun. 2003. PMID: 14599847
-
Reestablishing T Cell Tolerance by Antibody-Based Therapy in Type 1 Diabetes.Arch Immunol Ther Exp (Warsz). 2015 Aug;63(4):239-50. doi: 10.1007/s00005-015-0336-z. Epub 2015 Mar 20. Arch Immunol Ther Exp (Warsz). 2015. PMID: 25790749 Review.
-
Cooperative roles of CTLA-4 and regulatory T cells in tolerance to an islet cell antigen.J Exp Med. 2004 Jun 21;199(12):1725-30. doi: 10.1084/jem.20040124. J Exp Med. 2004. PMID: 15210748 Free PMC article.
-
Advances in type I diabetes associated tolerance mechanisms.Scand J Immunol. 2008 Jul;68(1):1-11. doi: 10.1111/j.1365-3083.2008.02120.x. Epub 2008 May 9. Scand J Immunol. 2008. PMID: 18482207 Review.
-
TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes.Nat Med. 2003 Sep;9(9):1202-8. doi: 10.1038/nm924. Epub 2003 Aug 24. Nat Med. 2003. PMID: 12937416
Cited by
-
Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?Clin Dev Immunol. 2011;2011:432016. doi: 10.1155/2011/432016. Epub 2011 Jul 18. Clin Dev Immunol. 2011. PMID: 21785616 Free PMC article. Review.
-
Dietary gluten alters the balance of pro-inflammatory and anti-inflammatory cytokines in T cells of BALB/c mice.Immunology. 2013 Jan;138(1):23-33. doi: 10.1111/imm.12007. Immunology. 2013. PMID: 22913724 Free PMC article.
-
Impact of dietary gluten on regulatory T cells and Th17 cells in BALB/c mice.PLoS One. 2012;7(3):e33315. doi: 10.1371/journal.pone.0033315. Epub 2012 Mar 13. PLoS One. 2012. PMID: 22428018 Free PMC article.
-
Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes.Nat Rev Drug Discov. 2011 Jun;10(6):439-52. doi: 10.1038/nrd3402. Nat Rev Drug Discov. 2011. PMID: 21629294 Review.
-
MAS-1 adjuvant immunotherapy generates robust Th2 type and regulatory immune responses providing long-term protection from diabetes in late-stage pre-diabetic NOD mice.Autoimmunity. 2014 Aug;47(5):341-50. doi: 10.3109/08916934.2014.910768. Epub 2014 May 1. Autoimmunity. 2014. PMID: 24783965 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical